The effects of lipoxin A and lipoxin B on functional responses of human granulocytes.

[1]  M. Ingelman-Sundberg,et al.  Activation of protein kinase C by lipoxin A and other eicosanoids. Intracellular action of oxygenation products of arachidonic acid. , 1986, Biochemical and biophysical research communications.

[2]  C. Serhan,et al.  Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity: effects on intracellular cAMP and target cell binding. , 1985, Journal of immunology.

[3]  J. Palmblad,et al.  Effects of leukotrienes and f-Met-Leu-Phe on oxidative metabolism of neutrophils and eosinophils. , 1984, Journal of immunology.

[4]  E. Goetzl,et al.  Heterogeneity of Human Polymorphonuclear Leukocyte Receptors for Leukotriene B4 Identification of a Subset of High Affinity Receptors That Transduce the Chemotactic Response , 1980 .

[5]  B. Samuelsson.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.

[6]  J. Palmblad,et al.  Leukotriene‐induced neutrophil aggregation in vitro , 1982, FEBS letters.

[7]  G. Weissmann,et al.  Leukotriene B4 is a complete secretagogue in human neutrophils: a kinetic analysis. , 1982, Biochemical and biophysical research communications.

[8]  B. Seligmann,et al.  Adaptation of human neutrophil responsiveness to the chemoattractant N-formylmethionylleucylphenylalanine. Heterogeneity and/or negative cooperative interaction of receptors. , 1982, The Journal of biological chemistry.

[9]  B. Samuelsson,et al.  Stimulation of human leukocyte degranulation by leukotriene B4 and its ω‐oxidized metabolites , 1981 .

[10]  J. Palmblad,et al.  Leukotriene B4 — a stereospecific stimulator for release of lysosomal enzymes from neutrophils , 1981, FEBS letters.

[11]  E. Goetzl,et al.  The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). , 1980, Journal of immunology.

[12]  C. Smith,et al.  Motility and adhesiveness in human neutrophils. Effects of chemotactic factors. , 1979, The Journal of clinical investigation.